Early short course of neuromuscular blocking agents in patients with covid-19 ards: a propensity score analysis

HIGHLIGHTS

• who: Gianluigi Li Bassi from the Chermside, Brisbane, QLD, Australia have published the Article: Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis, in the Journal: (JOURNAL) of February/27,/2020
• what: The authors aimed to investigate in COVID-19 patients with moderate-to-severe ARDS the impact of early use of NMBAs on 90-day mortality through propensity score (PS) matching analysis. The aim in the PS-matched cohort was comparison between groups in 90-day in-hospital mortality assessed through Cox proportional hazard modeling. At . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.